Examination of toxicity and collagen linearity after the administration of the protein cross-linker genipin in equine tendon and dermis: a pilot study.

The research article describes a pilot study examining the toxicity and collagen linearity following the administration of genipin, a protein cross-linker, in equine (horse) tendon and dermis tissue. The findings suggest that genipin is well-tolerated as a therapeutic agent for collagen stabilization, without showing any systemic toxicity or hypersensitivity.

Methods

• The researchers injected high doses of a cross-linker called genipin (GP) directly into the tendons and dermis of yearling horses.
• For the tendon experiment, the horses were evaluated at various times up to 30 days post-injection, while for the dermis experiment, evaluations were conducted up to 1 year after treatment.
• The health impacts and potential toxicity were measured through numerous metrics such as lameness, swelling, ultrasound evaluation, blood parameters, and microscopic morphologies of collagen production.

Results

• Post injection, mild lameness and swelling were observed in the tendons. However, there was no systemic toxicity, meaning no harmful effects on the animal’s whole biological system, and no collagen stabilization defects.
• Microscopic evaluation showed an increase in linear collagen in treated tendons, suggesting that the genipin injection successfully enhances collagen stabilization in tendon tissues.
• Similar mild swelling occurred in the dermis at the injection site. There was a temporary decrease in dermal collagen 30 days post-injection, but after 1 year, the high-dose injection site showed an increase in mature collagen, similar to untreated sites. This might mean that the GP has a long-term beneficial effect on collagen formation in the dermis.

Conclusions

• The results suggest that GP injections are well-tolerated in equine tendon and dermis tissue. No systemic hypersensitivity or toxicities were observed in the subjects, implying that GP is not harmful on a biological level.
• From a microscopic perspective, the GP injections resulted in increased linear collagen in tendons at 30 days post-injection, and an overall increase in collagen in dermal tissue when evaluated 1 year post-injection.
• As such, the results of this study suggest that genipin could potentially be used as a safe and effective therapeutic agent for collagen stabilization in equine medicine.